Although mergers and acquisitions (M&A) activity has not seen a
The US Food and Drug Administration (FDA) has released
The biopharma industry is facing a significant challenge
Big pharmaceutical companies that manufacture personalized
As the pharmaceutical industry continues to advance
In response to growing concerns over medicine shortages
Pfizer has announced plans to progress with a reworked
Artificial intelligence (AI) is poised to revolutionize supply
The contract market for antibody drug conjugates (ADCs) is set for double-digit growth
Earlier this month, the FDA published its annual report